Comparison of choroidal thickness changes following intravitreal dexamethasone ranibizumab and triamcinolone in eyes with retinal vein occlusion
Yazarlar (3)
Erhan Yumusak Kirikkale Üniversitesi, Türkiye
Prof. Dr. Kemal ÖRNEK Kirikkale Üniversitesi, Türkiye
Nevin H. Dikel Kirikkale Üniversitesi, Türkiye
| Makale Türü | Özgün Makale (SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale) | ||
| Dergi Adı | European Journal of Ophthalmology | ||
| Dergi ISSN | 1120-6721 Wos Dergi Scopus Dergi | ||
| Dergi Tarandığı Indeksler | SCI-Expanded | ||
| Makale Dili | İngilizce | Basım Tarihi | 11-2016 |
| Kabul Tarihi | 12-04-2026 | Yayınlanma Tarihi | – |
| Cilt / Sayı / Sayfa | 26 / 6 / 627–632 | DOI | 10.5301/ejo.5000734 |
| Özet |
| PurposeTo evaluate short-term choroidal thickness changes following intravitreal dexamethasone implant (DEX), ranibizumab (RAN), and triamcinolone acetonide (TA) in eyes with retinal vein occlusion (RVO) and macular edema (ME).MethodsIn this prospective study, 35 eyes of 35 patients with RVO and ME who were treated with intravitreal injections of DEX, RAN, and TA were included. Choroidal thickness was measured using semiautomated segmentation of enhanced depth imaging with optical coherence tomography at fovea and parafoveal areas. Changes in choroidal thickness following treatment were compared statistically.ResultsChoroidal thickness decreased following DEX, RAN, and TA treatments (all p>0.05). In the DEX group, at the first month nasal 1,500 µm (N11,500) and at the third month subfoveal (SF3) and nasal 500 µm (N3500) choroidal thickness revealed a significant reduction compared … |
| Anahtar Kelimeler |
| Choroidal thickness | Dexamethasone | Intravitreal | Ranibizumab | Retinal vein occlusion | Triamcinolone |
BM Sürdürülebilir Kalkınma Amaçları
| Atıf Sayıları | |
| Google Scholar | 30 |
| Scopus | 3 |
| Web of Science | 13 |